ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-01085
製品名称
VLDLR Protein, Human, Recombinant (His)
タンパク質名
VLDLR
Species
Human
HOST
HEK293 Cells
100μg: -
お問い合わせ

Overview

Synonyms VLDLRCH, CAMRQ1, CHRMQ1, very low density lipoprotein receptor, CARMQ1
Characteristics 1.Measured by its binding ability in a functional ELISA.
2. Immobilized human VLDLR-His at 10μg/mL (100μL/well) can bind biotinylated human LRPAP1-His , the EC50 of biotinylated human LRPAP1-His is 0.05-0.2 μg/mL.
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity 79.10%
Description The very low density lipoprotein receptor, known as VLDLR, is a single-pass type 1 integral membrance protein and a member of the LDL receptor family. This receptor family includes LDL receptor, LRP, megalin, VLDLR and ApoER2, and is characterized by a cluster of cysteine-rich class A repeats, epidermal growth factor (EGF)-like repeats, YWTD repeats and an O-linked sugar sdomain. VLDLR contains 3 EGF-like domains, 8 LDL-receptor class A domains, as well as 6 LDL-receptor class B repeats, and is abundant in heart, skeletal muscle, also ovary and kidney, but not in liver. VLDLR binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. VLDLR mediates the phosphorylation of mDab1 (mammalian disabled protein) via binding to Reelin, and induces the modulation of Tau phosphorylation. This pathway regulates the migration of neurons along with the radial glial fiber network during brain development. Defects of VLDLR may be the cause of VLDLR-associated cerebellar hypoplasia (VLDLRCH), a syndrome characterized by moderate-to-profound mental retardation, delayed ambulation, and predominantly truncal ataxia.
Reference Moheb, L.A. et al., 2008, Eur. J. Hum. Genet.?16?(2): 270-273.,Tiebel, O. et al., 1999. Atherosclerosis 145: 239-251.,Hiesberger, T. et al., 1999. Neuron 24: 481-489.,Sato, A. et al., 1999. Biochem. J. 341: 377-383.,Mikhailenko, I. et al., 1999. J. Cell Sci. 112: 3269-3281.,Boycott, K.M. et al., 2005,?Am. J. Hum. Genet.?77?(3): 477-483.,Trommsdorff, M. et al., 1999. Cell. 97: 689-701.
URL https://www.targetmol.com/recombinant-protein/vldl_receptor_vldlr_protein_human_recombinant_his_tag_

お問い合わせリスト(-)

お問い合わせフォーム